Global Bentonite Market Growth, Market Insights and Forecast to 2025Posted by rekha on October 11th, 2019 The global multiple sclerosis drugs market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Factors which are influencing the market growth are growing research in the field of MS to develop innovative therapies, increasing awareness about the disease and rising healthcare expenditures. However, high cost related with treatment of drugs, lack of availability of drugs and stringent regulatory approvals are hampering the market growth. Moreover, technological advancements in biomedical science and new product launches would act as major opportunities for the market growth. Global multiple sclerosis drugs market segmented on the basis of drug class, route of administration, distribution channel, and region. For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=15731 Orally Administrated Products Dominate the Global Multiple Sclerosis Drugs Market Several oral treatments have shown benefit and will generate much interest because of the convenience of such administration. New oral drugs recently approved for MS treatment represent significant advances in therapy. Three oral drugs have been approved by regulatory agencies for MS treatment such as fingolimod, teriflunomide, and dimethyl fumarate. Thus, increasing the segment demand in this market. North America Leads the Global Multiple Sclerosis Drugs market
PBI’s global multiple sclerosis drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.This region is one of the key markets for multiple sclerosis drugs. The region has witnessed considerable growth in this market owing to the supportive medical reimbursement policies, huge sales of multiple sclerosis drugs in countries such as the U.S. and Canada. Asia Pacific is expected to grow with a steady growth rate due to increasing investments made by major market players in therapeutic drugs, introducing new products and rising patient with this disease in countries such as Japan and China. New Product Launch are the Key Strategies Adopted by Market Players
Global multiple sclerosis drugs market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2018, Sanofi launched multiple sclerosis treatment drug in India. This product has the potential to offer an efficacious and convenient treatment regimen of just once a day oral tablet, vis-a-vis commonly available injectable treatment options. Key player’s profiles in the report are Teva Pharmaceutical industries Ltd. (Israel), Sanofi S.A. (France), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Medtronic plc (Questcor Pharmaceuiticals) (U.S.), Biogen, Inc. (U.S.), Bayer AG (Germany), Acorda Therapeuitics (U.S.) and GlaxoSmithKline. Precision Business Insights (PBI) in its report titled “Global Multiple Sclerosis Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market. Detailed Segmentation
By Drug Class o Steroids o Others o Disease Modifying Drugs (DMDs) By Route of Administration o Parenteral o Oral By Distribution Channel o Retail Pharmacy o Online Pharmacy o Hospital Pharmacy By Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-multiple-sclerosis-drugs-market/ Like it? Share it! More by this author |